SCEMBLIX® (asciminib) tablets HCP Company Details: 77 Social Audience

SCEMBLIX® (asciminib) tablets HCP Overview

Website: scemblix-hcp.com
Industry: Pharmaceutical Manufacturing
Employees: 1
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About SCEMBLIX® (asciminib) tablets HCP

This information is for US health care professionals only. SCEMBLIX is a Novartis product and is not associated with any individual users on LinkedIn. Please see full Prescribing Information for SCEMBLIX at bit.ly/SCEMBPI. To report SUSPECTED ADVERSE REACTIONS, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 265985 3/23